Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur (Q34981015)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur (English)

1 reference

Europe PubMed Central

5 August 2017

object named as

Joseph B Sempa

1

0 references

4

object named as

Moses R Kamya

1 reference

Europe PubMed Central

5 August 2017

2

object named as

Agnes N Kiragga

1 reference

Europe PubMed Central

5 August 2017

Barbara Castelnuovo

3

object named as

Barbara Castelnuovo

1 reference

Europe PubMed Central

5 August 2017

author name string

Yukari C Manabe

5

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

27 August 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

e73190

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

27 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

HIV RNA suppression and immune restoration: can we do better?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Evidence that androgens modulate human thymic T cell output.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Restoration of the immune system with anti-retroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

8 July 2018

Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

CD4 T-cell responses to combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3754935

26 October 2018

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Low CD4+T Cell Nadir Is an Independent Predictor of Lower HIV‐Specific Immune Responses in Chronically HIV‐1–Infected Subjects Receiving Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073190

21 January 2018

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24013838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

1 reference

https://pubmed.ncbi.nlm.nih.gov/24013838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24013838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/24013838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0073190

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...873190S

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34981015&oldid=1864127704"